Apposite Capital

Apposite Capital is a specialist pan-European investor in healthcare and life sciences, providing institutional capital to healthcare SMEs with the aim of scaling them into sustainable platforms. The firm invests growth and buyout capital across the sector, including health-technology scaleups, and describes its focus as high-potential, high-impact healthcare opportunities. Its stated experience is decades of investing in and scaling health businesses.

The firm structures investments around a set of defined situations: growth capital for healthcare SMEs seeking to expand; management buyouts and buy-ins, supporting management teams in acquiring businesses; retirement sales, which address owner succession; and founder transitions, covering ownership change among founder-led companies. Alongside capital, Apposite provides hands-on strategic and operational value-creation support to portfolio businesses, drawing on a network of healthcare leaders.

Sector concentration is deliberate. The investment domains are healthcare, life sciences and healthcare investment and value creation, with portfolio activity concentrated in healthcare SMEs. The stated impact objectives are improving quality, increasing access and promoting innovation in healthcare, and the firm reports promoting ESG practices, diversity and equality initiatives, and employee and community engagement across its portfolio companies. Working relationships with management teams are described as collaborative.

Geographic coverage is pan-European. Funding details, founding year and team size are not disclosed in the information available here.